148 related articles for article (PubMed ID: 29683097)
21. Pyr3 Induces Apoptosis and Inhibits Migration in Human Glioblastoma Cells.
Chang HH; Cheng YC; Tsai WC; Tsao MJ; Chen Y
Cell Physiol Biochem; 2018; 48(4):1694-1702. PubMed ID: 30078005
[TBL] [Abstract][Full Text] [Related]
22. Cytostatic in vitro effects of DTCM-glutarimide on bladder carcinoma cells.
Brassesco MS; Pezuk JA; Morales AG; de Oliveira JC; Valera ET; da Silva GN; de Oliveira HF; Scrideli CA; Umezawa K; Tone LG
Asian Pac J Cancer Prev; 2012; 13(5):1957-62. PubMed ID: 22901154
[TBL] [Abstract][Full Text] [Related]
23. Combination treatment for glioblastoma with temozolomide, DFMO and radiation.
Alexiou GA; Vartholomatos E; I Tsamis K; Peponi E; Markopoulos G; A Papathanasopoulou V; Tasiou I; Ragos V; Tsekeris P; Kyritsis AP; Galani V
J BUON; 2019; 24(1):397-404. PubMed ID: 30941997
[TBL] [Abstract][Full Text] [Related]
24. BRM270, a Compound from Natural Plant Extracts, Inhibits Glioblastoma Stem Cell Properties and Glioblastoma Recurrence.
Jeon HY; Park CG; Ham SW; Choi SH; Lee SY; Kim JY; Seo S; Jin X; Kim JK; Eun K; Kim EJ; Kim H
J Med Food; 2017 Sep; 20(9):838-845. PubMed ID: 28792781
[TBL] [Abstract][Full Text] [Related]
25. A New Chalcone Derivative with Promising Antiproliferative and Anti-Invasion Activities in Glioblastoma Cells.
Mendanha D; Vieira de Castro J; Moreira J; Costa BM; Cidade H; Pinto M; Ferreira H; Neves NM
Molecules; 2021 Jun; 26(11):. PubMed ID: 34205043
[TBL] [Abstract][Full Text] [Related]
26. 3-[(dodecylthiocarbonyl)methyl]-glutarimide attenuates graft arterial disease by suppressing alloimmune responses and vascular smooth muscle cell proliferation.
Zaitsu M; Yamashita K; Shibasaki S; Tsunetoshi Y; Fukai M; Ogura M; Yoshida T; Igarashi R; Kobayashi N; Umezawa K; Todo S
Transplantation; 2015 May; 99(5):948-56. PubMed ID: 25675200
[TBL] [Abstract][Full Text] [Related]
27. Highly efficient radiosensitization of human glioblastoma and lung cancer cells by a G-quadruplex DNA binding compound.
Merle P; Gueugneau M; Teulade-Fichou MP; Müller-Barthélémy M; Amiard S; Chautard E; Guetta C; Dedieu V; Communal Y; Mergny JL; Gallego M; White C; Verrelle P; Tchirkov A
Sci Rep; 2015 Nov; 5():16255. PubMed ID: 26542881
[TBL] [Abstract][Full Text] [Related]
28. The natural compound n-butylidenephthalide derived from Angelica sinensis inhibits malignant brain tumor growth in vitro and in vivo.
Tsai NM; Chen YL; Lee CC; Lin PC; Cheng YL; Chang WL; Lin SZ; Harn HJ
J Neurochem; 2006 Nov; 99(4):1251-62. PubMed ID: 16987298
[TBL] [Abstract][Full Text] [Related]
29. Mangiferin induces radiosensitization in glioblastoma cells by inhibiting nonhomologous end joining.
Mu F; Liu T; Zheng H; Xie X; Lei T; He X; Du S; Tong R; Wang Y
Oncol Rep; 2018 Dec; 40(6):3663-3673. PubMed ID: 30272350
[TBL] [Abstract][Full Text] [Related]
30. PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment.
Cenciarelli C; Marei HE; Zonfrillo M; Pierimarchi P; Paldino E; Casalbore P; Felsani A; Vescovi AL; Maira G; Mangiola A
Mol Cancer; 2014 Nov; 13():247. PubMed ID: 25380967
[TBL] [Abstract][Full Text] [Related]
31. Experimental and clinical studies on radiation and curcumin in human glioma.
Sminia P; van den Berg J; van Kootwijk A; Hageman E; Slotman BJ; Verbakel WFAR
J Cancer Res Clin Oncol; 2021 Feb; 147(2):403-409. PubMed ID: 33118056
[TBL] [Abstract][Full Text] [Related]
32. Characterization of structurally distinct, isoform-selective phosphoinositide 3'-kinase inhibitors in combination with radiation in the treatment of glioblastoma.
Chen JS; Zhou LJ; Entin-Meer M; Yang X; Donker M; Knight ZA; Weiss W; Shokat KM; Haas-Kogan D; Stokoe D
Mol Cancer Ther; 2008 Apr; 7(4):841-50. PubMed ID: 18413797
[TBL] [Abstract][Full Text] [Related]
33. Combination therapy of cilengitide with belotecan against experimental glioblastoma.
Kim YH; Lee JK; Kim B; DeWitt JP; Lee JE; Han JH; Kim SK; Oh CW; Kim CY
Int J Cancer; 2013 Aug; 133(3):749-56. PubMed ID: 23354807
[TBL] [Abstract][Full Text] [Related]
34. BUB1 and BUBR1 inhibition decreases proliferation and colony formation, and enhances radiation sensitivity in pediatric glioblastoma cells.
Morales AG; Pezuk JA; Brassesco MS; de Oliveira JC; de Paula Queiroz RG; Machado HR; Carlotti CG; Neder L; de Oliveira HF; Scrideli CA; Tone LG
Childs Nerv Syst; 2013 Dec; 29(12):2241-8. PubMed ID: 23728478
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of RANKL- and LPS-induced osteoclast differentiations by novel NF-κB inhibitor DTCM-glutarimide.
Koide N; Kaneda A; Yokochi T; Umezawa K
Int Immunopharmacol; 2015 Mar; 25(1):162-8. PubMed ID: 25617668
[TBL] [Abstract][Full Text] [Related]
36. Concomitant administration of radiation with eribulin improves the survival of mice harboring intracerebral glioblastoma.
Miki S; Imamichi S; Fujimori H; Tomiyama A; Fujimoto K; Satomi K; Matsushita Y; Matsuzaki S; Takahashi M; Ishikawa E; Yamamoto T; Matsumura A; Mukasa A; Nishikawa R; Masutomi K; Narita Y; Masutani M; Ichimura K
Cancer Sci; 2018 Jul; 109(7):2275-2285. PubMed ID: 29758120
[TBL] [Abstract][Full Text] [Related]
37. Chloroquine inhibits the malignant phenotype of glioblastoma partially by suppressing TGF-beta.
Roy LO; Poirier MB; Fortin D
Invest New Drugs; 2015 Oct; 33(5):1020-31. PubMed ID: 26271735
[TBL] [Abstract][Full Text] [Related]
38. The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells.
Atif F; Patel NR; Yousuf S; Stein DG
PLoS One; 2015; 10(6):e0131441. PubMed ID: 26110872
[TBL] [Abstract][Full Text] [Related]
39. Melanoma differentiation-associated 7 (interleukin 24) inhibits growth and enhances radiosensitivity of glioma cells in vitro and in vivo.
Yacoub A; Mitchell C; Lister A; Lebedeva IV; Sarkar D; Su ZZ; Sigmon C; McKinstry R; Ramakrishnan V; Qiao L; Broaddus WC; Gopalkrishnan RV; Grant S; Fisher PB; Dent P
Clin Cancer Res; 2003 Aug; 9(9):3272-81. PubMed ID: 12960112
[TBL] [Abstract][Full Text] [Related]
40. The radiosensitization effect of titanate nanotubes as a new tool in radiation therapy for glioblastoma: a proof-of-concept.
Mirjolet C; Papa AL; Créhange G; Raguin O; Seignez C; Paul C; Truc G; Maingon P; Millot N
Radiother Oncol; 2013 Jul; 108(1):136-42. PubMed ID: 23647757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
